Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study
Pietro De Luca, Angelo Camaioni, Pasquale Marra, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2552-2552
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
Farigol Hakem Zadeh, Daniel R. Wilson, Devendra K. Agrawal
Archives of Microbiology & Immunology (2023) Vol. 07, Iss. 02
Open Access | Times Cited: 26
Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis
Maria Teresa Rocchetti, Francesco Bellanti, Mariia Zadorozhna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8824-8824
Open Access | Times Cited: 21
Luteolin for neurodegenerative diseases: a review
Dunuvilla Kavindi Jayawickreme, Cletus Ekwosi, Apurva Anand, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 644-664
Open Access | Times Cited: 13
Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives
Katharine A. Seton, José Espejo, Karen Giménez-Orenga, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 8
Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) binding to angiotensin‐converting enzyme 2
Junjie Zhu, Huimin Yan, Mengyao Shi, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3508-3521
Closed Access | Times Cited: 16
Treatable traits for long COVID
Hayley Lewthwaite, Anthony Byrne, Bruce J. Brew, et al.
Respirology (2023) Vol. 28, Iss. 11, pp. 1005-1022
Open Access | Times Cited: 15
Intervention modalities for brain fog caused by long-COVID: systematic review of the literature
Alon Gorenshtein, Tom Liba, Liron Leibovitch, et al.
Neurological Sciences (2024) Vol. 45, Iss. 7, pp. 2951-2968
Open Access | Times Cited: 5
A Narrative Review of the Efficacy of Long COVID Interventions on Brain Fog, Processing Speed, and Other Related Cognitive Outcomes
Bryana Whitaker-Hardin, Keith McGregor, Gitendra Uswatte, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 421-421
Open Access
Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies
Anna Paola Capra, Alessio Ardizzone, Lelio Crupi, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2189-2189
Open Access | Times Cited: 13
Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics
Elena Cantone, Luca D’Ascanio, Pietro De Luca, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 7, pp. 3671-3678
Open Access | Times Cited: 4
Long‐term olfactory loss post‐COVID‐19: Pathobiology and potential therapeutic strategies
Sarah Kim, John B. Finlay, Tiffany Ko, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery (2024) Vol. 10, Iss. 2, pp. 148-155
Open Access | Times Cited: 4
Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial
Arianna Di Stadio, Salvatore Gallina, Salvatore Cocuzza, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 280, Iss. 11, pp. 4949-4961
Open Access | Times Cited: 11
Exploration of the Core Pathways and Potential Targets of Luteolin Treatment on Late-Onset Depression Based on Cerebrospinal Fluid Proteomics
Kaige Liu, Huizhen Li, Ning-Xi Zeng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3485-3485
Open Access | Times Cited: 10
Co-ultraPEALut in Subjective Cognitive Impairment Following SARS-CoV-2 Infection: An Exploratory Retrospective Study
Valentina Cenacchi, Giovanni Furlanis, Alina Menichelli, et al.
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 293-293
Open Access | Times Cited: 3
CURRENT CONCEPTS IN LONG-COVID BRAIN FOG AND POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
Jinny Tavee
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 5, pp. 522-530
Closed Access | Times Cited: 3
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition
Jennifer Frontera, Alla Guekht, Ricardo Allegri, et al.
Journal of the Neurological Sciences (2023) Vol. 454, pp. 120827-120827
Closed Access | Times Cited: 9
Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?
Arianna Di Stadio, Evanthia Bernitsas, Ignazio La Mantia, et al.
Life (2023) Vol. 13, Iss. 1, pp. 226-226
Open Access | Times Cited: 8
Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial
Arianna Di Stadio, Elena Cantone, Pietro De Luca, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1109-1109
Open Access | Times Cited: 8
Tackling persistent neurological symptoms in patients following acute COVID-19 infection: an update of the literature
Eder Cáceres, Afshin A. Divani, André Emilio Viñán Garcés, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-17
Open Access | Times Cited: 2
Mechanism and treatment of olfactory dysfunction caused by coronavirus disease 2019
Bian Hu, Mengdan Gong, Yizhen Xiang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
A. M. Das, Swarnali Khan, Syamal Roy, et al.
(2023), pp. 336-376
Open Access | Times Cited: 6
Narcolepsy—A Neuropathological Obscure Sleep Disorder: A Narrative Review of Current Literature
Vishal Chavda, Bipin Chaurasia, Giuseppe Emmanuele Umana, et al.
Brain Sciences (2022) Vol. 12, Iss. 11, pp. 1473-1473
Open Access | Times Cited: 10
Fear of COVID-19 and Anxiety: Serial Mediation by Trust in the Government and Hope
Yong Yang, Huili Wang
Psychology Research and Behavior Management (2023) Vol. Volume 16, pp. 963-970
Open Access | Times Cited: 5
A Decades-Long Journey of Palmitoylethanolamide (PEA), as a Cornerstone in Chronic Neuropathic Pain Management: A Comprehensive Narrative Review
Giustino Varrassi, Antonella Paladini, C. Corno, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top